Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Arizona Comprehensive Cancer Center
Tucson, Arizona, United States
- City of Hope
Duarte, California, United States
- University of California at San Diego
La Jolla, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- University of Chicago
Chicago, Illinois, United States
- Ochsner Foundation Clinic
New Orleans, Louisiana, United States
- Eastern Maine Medical Center
Brewer, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Cape Cod Healthcare
Hyannis, Massachusetts, United States
- Newton-Wellesley Hospital
Newton, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- New Hampshire Oncology and Hematology
Concord, New Hampshire, United States
- New Hampshire Oncology and Hematology
Hooksett, New Hampshire, United States
- New Hampshire Oncology and Hematology
Laconia, New Hampshire, United States
- State University of New York Downstate Medical Center
Brooklyn, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- North Shore Long Island Jewish Health System
Lake Success, New York, United States
- Columbia University
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- Oregon Health and Sciences
Portland, Oregon, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 28 Feb 2022
- Completion
- 31 Dec 2026
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 729
- Registry id
- NCT01208662
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.